Skip to main content
Premium Trial:

Request an Annual Quote

Dow Extends Genomatica Agreement

NEW YORK, May 3 (GenomeWeb News) - Genomatica last week said that it has extended a research agreement with the Dow Chemical Company that began in 2002, after successfully achieving "a series of scientific milestones."

 

Under the terms of the extended agreement, Dow has licensed Genomatica's SimPheny modeling and simulation technology, which it will use to improve recombinant protein expression from specially designed strains of Pseudomonas fluorescens. Scientists at Genomatica will collaborate with Dow researchers on the project.

 

Financial terms of the expanded agreement were not disclosed.

 

 

The Scan

Highly Similar

Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News.

Gain of Oversight

According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research.

Lasker for mRNA Vaccine Work

The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners

PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC

In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.